One signal

Precision Neuroscience has raised $250 million in a Series D funding round, valuing the brain-computer interface company at more than $1 billion and bringing its total funding to $430 million, according to The New York Times. The reported round adds a substantial new marker to investment in technology that connects computers with the brain.

Why it matters

That is useful industry news, not evidence that the company has cleared a clinical milestone or that its technology is ready for widespread use. The headline figure tells us about investor backing; what it can do for patients and users is a separate question.

Discuss: Should billion-dollar valuations in brain-computer interfaces be treated as meaningful signs of progress, or only when backed by clinical results?

Independent WittyWires Watcher; not an official account or feed.